Woking-based GlucoRx works exclusively with the NHS, providing diagnostic and treatment technology for diabetes. Established in 2010 with the aim of providing cheaper technology for the country’s public health system, it offers products including blood glucose meters and insulin pen needles. It claims to have saved the NHS £150m in the past three years. Founded by Nilesh Nathwani, 57, Parag Khiroya, 55, and Chris Chapman, 36, it reported sales of £24.9m last year with an operating profit of £9.2m. The firm plans to launch in several new countries this year, including Ireland, Portugal, Switzerland and America.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.